Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Molina Healthcare Inc (NYSE: MOH) closed at $147.03 down -3.94% from its previous closing price of $153.06. In other words, the price has decreased by -$3.94 from its previous closing price. On the day, 2.19 million shares were traded. MOH stock price reached its highest trading level at $153.49 during the session, while it also had its lowest trading level at $146.13.
Ratios:
For a deeper understanding of Molina Healthcare Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.92.
On October 16, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $203.
On October 14, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $207.Goldman initiated its Neutral rating on October 14, 2025, with a $207 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 06 ’25 when ROMNEY RONNA sold 700 shares for $153.74 per share. The transaction valued at 107,618 led to the insider holds 17,131 shares of the business.
WOYS JAMES bought 10,000 shares of MOH for $1,559,365 on Aug 04 ’25. The Chief Operating Officer now owns 74,331 shares after completing the transaction at $155.94 per share. On Aug 04 ’25, another insider, ROMNEY RONNA, who serves as the Director of the company, bought 700 shares for $157.99 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 7557341696 and an Enterprise Value of 2962341888. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 9.11, and their Forward P/E ratio for the next fiscal year is 9.85. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17 while its Price-to-Book (P/B) ratio in mrq is 1.79. Its current Enterprise Value per Revenue stands at 0.069 whereas that against EBITDA is 2.033.
Stock Price History:
The Beta on a monthly basis for MOH is 0.55, which has changed by -0.5408981 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, MOH has reached a high of $359.97, while it has fallen to a 52-week low of $147.75. The 50-Day Moving Average of the stock is -19.22%, while the 200-Day Moving Average is calculated to be -42.18%.
Shares Statistics:
For the past three months, MOH has traded an average of 1.46M shares per day and 2554420 over the past ten days. A total of 51.00M shares are outstanding, with a floating share count of 50.83M. Insiders hold about 1.10% of the company’s shares, while institutions hold 106.51% stake in the company. Shares short for MOH as of 1760486400 were 3221202 with a Short Ratio of 2.20, compared to 1757894400 on 3061574. Therefore, it implies a Short% of Shares Outstanding of 3221202 and a Short% of Float of 8.430000399999999.
Earnings Estimates
A detailed examination of Molina Healthcare Inc (MOH) is currently in progress, with 16.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $4.58, with high estimates of $6.58 and low estimates of $2.7.
Analysts are recommending an EPS of between $18.92 and $13.26 for the fiscal current year, implying an average EPS of $14.99. EPS for the following year is $14.83, with 17.0 analysts recommending between $21.09 and $11.0.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $10.89B this quarter.It ranges from a high estimate of $11.29B to a low estimate of $10.45B. As of. The current estimate, Molina Healthcare Inc’s year-ago sales were $10.5BFor the next quarter, 12 analysts are estimating revenue of $11.64B. There is a high estimate of $12.19B for the next quarter, whereas the lowest estimate is $11.16B.
A total of 13 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $45.34B, while the lowest revenue estimate was $44.12B, resulting in an average revenue estimate of $44.79B. In the same quarter a year ago, actual revenue was $40.65BBased on 12 analysts’ estimates, the company’s revenue will be $47.13B in the next fiscal year. The high estimate is $48.42B and the low estimate is $44.85B.
